Cynata Therapeutics Ltd: Application for quotation of securities - CYP
Cynata Therapeutics Ltd: Cynata Presents at Bioshares Summit
Cynata Therapeutics Ltd: Proposed issue of securities - CYP
Cynata Therapeutics Ltd: Cynata to Acquire IP from Tekcyte
Cynata Therapeutics Ltd: Sharewise Investor Presentation
Cynata Therapeutics Ltd: CYP Presents at Major International Cell Therapy Conference
Cynata Therapeutics Ltd: Further GvHD Clinical Data Published in Nature Medicine
Cynata Therapeutics Ltd: Appendix 3Y-Dr Geoffrey Brooke
Cynata Therapeutics Ltd: Notification of cessation of securities - CYP
Cynata Therapeutics Ltd: Investor Presentation
Cynata Therapeutics Ltd: Quarterly Activity Report & Appendix 4C
Cynata Therapeutics Ltd: Notification regarding unquoted securities - CYP
Cynata Therapeutics Ltd: DFU Clinical Trial Enrolment Complete
Cynata Therapeutics Ltd: EU Approval for Phase 2 CYP-001 Trial in GvHD
Cynata Therapeutics Ltd: Cynata Presenting at Advanced Therapies Congress
Cynata Therapeutics Ltd: First Patient Treated in Phase 2 GvHD Trial
Cynata Therapeutics Ltd: Cynata Appoints New Chief Business Officer
Cynata Therapeutics Ltd: Encouraging Initial Data from CYP-006TK DFU Trial
Cynata Therapeutics Ltd: Appendix 4D & Half-Year Financial Statements
Cynata Therapeutics Ltd: Quarterly Activity Report & Appendix 4C
No Data